文献速递细菌感染、耐药与抗菌药物真菌感染医院感染防控

法国肾移植受者社区获得性肺炎住院患者的病因、临床特征、诊断检查与结局:多中心回顾性队列研究

Aetiology, clinical features, diagnostic studies, and outcomes of community-acquired pneumonia in kidney transplant recipients admitted to hospital: a multicentre retrospective French cohort study.
PubMed 文献 · Clin Microbiol Infect · 2022-12-24

该研究在法国10个中心回顾性纳入2016年1月至2018年12月因社区获得性肺炎(CAP)住院的肾移植受者,共165次CAP发作(132例患者)。微生物学检查在64/165(38.8%)次发作中检出呼吸道病原体,其中29/75株(38.7%)为机会性或耐药菌;26/165(15.8%)次发作需入住重症监护室。

要点

  • 165次CAP发作中64次(38.8%)检出病原体,含机会性与耐药菌。
  • 26/165(15.8%)次发作入住重症监护室,20/165(12.1%)需有创通气。
  • 支气管镜在87/165(52.7%)次发作中实施,39/87(44.8%)检出病原体。

核心结论

  • 法国肾移植受者CAP多发生于长期免疫抑制暴露者,微生物学检查在超过三分之一发作中检出病原体,包括耐药与机会性病原体。

研究设计与样本

  • 法国10个中心回顾性多中心研究,纳入2016年1月至2018年12月因CAP住院的肾移植受者,共165次CAP发作(132例患者),CAP出院诊断经临床与影像学核实。

主要发现

  • 从移植到入院的中位时间为6.4年(四分位距1.6-12.3年),112/165(67.9%)次发作有糖皮质激素暴露。
  • 痰培养在47/165(28.5%)次发作中实施,7/47(14.9%)阳性;支气管镜在87/165(52.7%)次发作中实施,39/87(44.8%)检出病原体。
  • 64/165(38.8%)次CAP发作检出呼吸道病原体,其中11/64(17.2%)为混合感染;64次发作共鉴定75株微生物,46/75(61.3%)为核心呼吸道病原体,29/75(38.7%)为机会性或耐药菌。
  • 机会性或耐药菌包括耶氏肺孢子菌9/75(12%)、铜绿假单胞菌5/75(6.7%)、耐多药肠杆菌科4/75(5.3%)、曲霉属4/75(5.3%)。
  • 26/165(15.8%)次发作需入住重症监护室,20/165(12.1%)需有创通气,22/165(13.3%)需住院期间透析。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the aetiology, clinical features, diagnostic studies and outcomes of community-acquired pneumonia (CAP) in a French cohort of hospitalized kidney transplant recipients. METHODS: We performed a retrospective, multicentre study in kidney transplant recipients admitted to ten French centres for CAP from January 2016 to December 2018. CAP discharge diagnoses were clinically and radiologically validated. We assessed a descriptive analysis of all confirmed CAP including medical ward and intensive care unit admissions. RESULTS: One hundred sixty-five CAP episodes in 132 patients were included. Median time from transplantation to admission was 6.4 (interquartile range, 1.6-12.3) years, with corticosteroid exposure in 112/165 (67.9%) cases. Sputum culture was performed in 47/165 (28.5%) cases including 7/47 (14.9%) positive samples. Bronchoscopy was performed in 87/165 (52.7%) cases with pathogens identified in 39/87 (44.8%) cases. Microbiological studies led to identifying a respiratory pathogen in 64/165 (38.8%) CAP episodes including 11/64 (17.2%) polymicrobial cases. Among these 64 episodes, 75 microorganisms were identified; 46/75 (61.3%) were core respiratory pathogens and 29/75 (38.7%) were opportunistic or drug-resistant organisms including Pneumocystis jirovecii 9/75 (12%), Pseudomonas aeruginosa 5/75 (6.7%), multidrug-resistant Enterobacteriaceae 4/75 (5.3%), and Aspergillus 4/75 (5.3%). Patients required intensive care unit admission in 26/165 (15.8%) episodes, invasive ventilation in 20/165 (12.1%) cases, and 22/165 (13.3%) needed in-hospital dialysis. DISCUSSION: CAP episodes occurred in kidney transplant recipients with a long history of immunosuppressive drug exposure. Diagnostic studies identified a microorganism in more than one-third of CAP episodes, including drug-resistant and opportunistic pathogens.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Schwartz B, Dupont V, Dury S, et al. Aetiology, clinical features, diagnostic studies, and outcomes of community-acquired pneumonia in kidney transplant recipients admitted to hospital: a multicentre retrospective French cohort study. Clin Microbiol Infect. 2022. PMID: 36574948. doi:10.1016/j.cmi.2022.12.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。